A randomized, multicenter, double-blind, parallel-design, phase 2 trial of oral MD-1100 acetate [linaclotide] administered for 14 days once daily at 100 microg, 300 microgg, 1000 microg, or placebo to patients with chronic constipation

Trial Profile

A randomized, multicenter, double-blind, parallel-design, phase 2 trial of oral MD-1100 acetate [linaclotide] administered for 14 days once daily at 100 microg, 300 microgg, 1000 microg, or placebo to patients with chronic constipation

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Oct 2006

At a glance

  • Drugs Linaclotide (Primary)
  • Indications Constipation
  • Focus Adverse reactions
  • Sponsors Ironwood Pharmaceuticals
  • Most Recent Events

    • 27 Oct 2006 Status change
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top